News

Vaxxinova exhibits at EuroTier 2022 – November 15-18, 2022

Nijmegen, the Netherlands – October, 2022 – from November 15-18  the Hanover Fairgrounds (Germany) will once again be the venue for one of the leading international trade fairs  for professional animal farming and livestock management, EuroTier 2022. After a cancelled edition in 2020 and a digital edition in 2021, the bi-annual trade fair is ready […]
Read more →

Vaxxinova announces new Chief Financial Officer (CFO)

Nijmegen, the Netherlands – September 1, 2022 – we are pleased to inform that Mariette Ferrari returns back to the Animal Health business, starting as Chief Financial Officer (CFO) for Vaxxinova per September 1, 2022. She succeeds Bart van der Looij as per that date. Mariëtte brings over 30 years of financial, IT and management […]
Read more →

Vaxxinova announces Chief Operating Officer (COO)

Nijmegen, the Netherlands – June 20, 2022 – We are pleased to announce the onboarding of Marcus Conradt as new COO at Vaxxinova, as of Monday June 20.Member of the Global Management Team, Marcus will be responsible for the coordination of production and R&D within Vaxxinova. Marcus is an experienced leader with proven management capabilities. […]
Read more →

Vaxxinova presents corporate movie

Nijmegen, NL – January 17, 2022 – Vaxxinova proudly presents its brand new corporate video. It gives an impression on our commitment to animal health, animal welfare and one health. Vaxxinova, we care.
Read more →

Vaxxinova Buys Newport Laboratories from Boehringer Ingelheim

Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […]
Read more →

Webinar Autogenous Vaccines on May 27th

May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH,  will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]
Read more →

Vaxxinova US Announces USDA Approval of Vaxxon® SRP® Pasteurella

March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine.  Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens.  Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]
Read more →

Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis

Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Read more →

“Boerderij” article on autogenous vaccines

Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.  
Read more →